Clinical Trials
Braintumor Website

There are 89 trials:
Facility: National Institutes of Health Clinical Center, 9000 Rockville Pike
Displaying 1 - 50
[1 - 50]     [51 - 89]    
NCT Trial Name# of Centers

NCT01434602

  Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas
18

NCT01222754

  Lenalidomide and Radiation Therapy in High Grade Gliomas or Diffuse Intrinsic Pontine Gliomas
6

NCT01295944

  Carboplatin and Bevacizumab for Recurrent Ependymoma
4

NCT01362803

  AZD6244 Hydrogen Sulfate for Children With Nervous System Tumors
4

NCT00001404

  Phenotype and Etiology of Pallister-Hall Syndrome
4

NCT00302159

  Valproic Acid With Temozolomide and Radiation Therapy to Treat Brain Tumors
3

NCT02019654

  An Investigation of the Biological and Neuronal Mechanisms of Post Traumatic Stress Disorder, Depression and Post-Concussive Syndrome Onset Following a Traumatic Brain Injury
2

NCT02019667

  Phase 2 Clinical Trial of SGS-742 Therapy in Succinic Semialdehyde Dehydrogenase Deficiency
2

NCT02107989

  Noninvasive Pre-surgical Evaluation of Patients With Focal Epilepsy
1

NCT02124083

  Phase 1/2 Study of Vorinostat Therapy in Niemann-Pick Disease, Type C1
1

NCT02281760

  Dabrafenib and Trametinib in People With BRAF V600E Mutation Positive Lesions in Erdheim Chester Disease
1

NCT02390752

  Phase I/II Trial of PLX3397 in Children and Young Adults With Refractory Leukemias and Refractory Solid Tumors Including Neurofibromatosis Type 1 (NF1) Associated Plexiform Neurofibromas (PN)
1

NCT02423044

  Spatial Context and Fear Learning
1

NCT02504892

  Everolimus Therapy in People With Birt-Hogg-Dube Syndrome (BHD)-Associated Kidney Cancer or Sporadic Chromophobe Renal Cancer
1

NCT02511015

  Hereditary Parkinson s Disease Natural History Protocol
1

NCT02639325

  Tumor Related Epilepsy
1

NCT02644512

  Phase II Trial of the MEK1/2 Inhibitor Selumetinib (AZD6244 Hydrogen Sulfate in Adults With Neurofibromatosis Type 1 (NF1) and Inoperable Plexiform Neurofibromas
1

NCT00001238

  Clinical Manifestations and Molecular Bases of Heritable Urologic Malignant Disorders
1

NCT00026884

  Collection of Serum and Tissue Samples From Patients With Biopsy-Proved or Suspected Malignant Disease
1

NCT01417546

  NHS-IL12 for Solid Tumors
1

NCT02709226

  Dose Escalation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
1

NCT00001159

  Evaluation of Patients With Thyroid Disorders
1

NCT00504218

  Detection and Treatment of Endocrine Abnormalities in Childhood Cancer Survivors
1

NCT00598351

  Natural History Study of Patients With Neurofibromatosis Type 2
1

NCT00605254

  PET Imaging of P-glycoprotein Function Using [11C]dLop
1

NCT00758108

  Characterization of WAGR Syndrome and Other Chromosome 11 Gene Deletions
1

NCT00880061

  An Open Label Dose Escalation Safety Study of Convection-Enhanced Delivery of IL13-PE38QQR in Patients With Progressive Pediatric Diffuse Infiltrating Brainstem Glioma and Supratentorial High-grade Glioma
1

NCT00924196

  Natural History Study of Patients With Neurofibromatosis Type I
1

NCT00924365

  Natural History Study of HIV Acquired in Infancy or Childhood
1

NCT00995007

  A Randomized Phase II Trial of Vandetanib (ZD6474) in Combination With Carboplatin Versus Carboplatin Alone Followed by Vandetanib Alone in Adults With Recurrent High-Grade Gliomas
1

NCT01117168

  Enrollment on the Childhood Cancer Research Network (CCRN) of the Children s Oncology Group
1

NCT01212094

  Double Blind Combination of Rituximab by Intravenous and Intrathecal Injection Versus Placebo in Patients With Low-Inflammatory Secondary Progressive Multiple Sclerosis (RIVITaLISe)
1

NCT01222728

  Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients
1

NCT01386450

  AZD6244 in Children With Low-Grade Gliomas
1

NCT01413438

  Bevacizumab With or Without Surgery for Adult Glioblastomas
1

NCT01417520

  Clinical and Basic Investigations Into Erdheim Chester Disease
1

NCT01419574

  Ultrasound and Other Images of Artery Blockages
1

NCT01222780

  To Evaluate the Safety, Activity and Pharmacokinetics of Marqibo in Children and Adolescents With Refractory Cancer
1

NCT01231932

  Investigating Molecular-Genetic Correlates of Fatigue Experienced by Cancer Patients Receiving Treatment
1

NCT01259479

  Satraplatin in Children and Young Adults With Refractory Solid Tumors Including Brain Tumors
1

NCT01273129

  Surgery as a Treatment for Medically Intractable Epilepsy
1

NCT00001595

  An Investigation of Pituitary Tumors and Related Hypothalmic Disorders
1

NCT00001686

  Evaluation, Treatment, and Natural History of Children With Cancer
1

NCT00001981

  The Treatment and Natural History of Acromegaly
1

NCT00005927

  Study of Adrenal Gland Tumors
1

NCT00009035

  Natural History of Patients With Brain and Spinal Cord Tumors
1

NCT00026780

  Eligibility Screening for a NCI Pediatric Oncology Branch Research Study
1

NCT00035373

  Eligibility Screening of Patients With Central Nervous System Tumors for the National Cancer Institute s (NCI) Clinical Research Protocols
1

NCT00046189

  Cancer Risk in Carriers of the Gene for Xeroderma Pigmentosum
1

NCT00054756

  Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
1



Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2017 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557
888-295-4740


Website Design By
World Wide Websites